Arcticzymes Technologies ASA
OSE:AZT

Watchlist Manager
Arcticzymes Technologies ASA Logo
Arcticzymes Technologies ASA
OSE:AZT
Watchlist
Price: 13.92 NOK -1.97% Market Closed
Market Cap: 724.4m NOK
Have any thoughts about
Arcticzymes Technologies ASA?
Write Note

Relative Value

The Relative Value of one AZT stock under the Base Case scenario is 30.7 NOK. Compared to the current market price of 13.92 NOK, Arcticzymes Technologies ASA is Undervalued by 55%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AZT Relative Value
Base Case
30.7 NOK
Undervaluation 55%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
92
vs Industry
45
Median 3Y
17.4
Median 5Y
21.9
Industry
8.1
Forward
6
vs History
80
vs Industry
2
Median 3Y
80.4
Median 5Y
73.4
Industry
23
Forward
47.3
vs History
92
vs Industry
4
Median 3Y
59
Median 5Y
60.9
Industry
23.4
vs History
vs Industry
0
Median 3Y
84.7
Median 5Y
73.7
Industry
27.3
vs History
98
vs Industry
23
Median 3Y
6.9
Median 5Y
12.5
Industry
2.6
vs History
93
vs Industry
41
Median 3Y
15.5
Median 5Y
21.2
Industry
8.1
Forward
4.6
vs History
93
vs Industry
41
Median 3Y
16.1
Median 5Y
19.3
Industry
9.6
vs History
90
vs Industry
2
Median 3Y
61.9
Median 5Y
60.4
Industry
4.3
Forward
32.6
vs History
63
vs Industry
1
Median 3Y
89.1
Median 5Y
76.5
Industry
3.8
Forward
35.9
vs History
93
vs Industry
4
Median 3Y
55.1
Median 5Y
56
Industry
6
vs History
vs Industry
1
Median 3Y
73.8
Median 5Y
71.8
Industry
3.8
vs History
98
vs Industry
20
Median 3Y
23
Median 5Y
31.5
Industry
4.8

Multiples Across Competitors

AZT Competitors Multiples
Arcticzymes Technologies ASA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Arcticzymes Technologies ASA
OSE:AZT
708.1m NOK 6.1 48.4 38.8 68.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 222 244.5 -176 911.8 -214 827.3 -212 375.8
US
Abbvie Inc
NYSE:ABBV
302.3B USD 5.4 59.5 14.9 22.9
US
Amgen Inc
NASDAQ:AMGN
160.6B USD 4.9 38 17.7 33.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.3B USD 11.9 -263.2 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
118.3B USD 4.2 939 10.4 10.4
US
Epizyme Inc
F:EPE
94.1B EUR 1 892.7 -483 -525.9 -511.9
AU
CSL Ltd
ASX:CSL
138.5B AUD 6.2 34.5 21.2 26.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
90.4B USD 6.5 19.4 17.9 19.9
US
Seagen Inc
F:SGT
39.3B EUR 18.2 -55.9 -60.1 -54.2
NL
argenx SE
XBRU:ARGX
33.4B EUR 18.3 -128.5 -103.2 -75.2
P/E Multiple
Earnings Growth
NO
Arcticzymes Technologies ASA
OSE:AZT
Average P/E: 189.8
48.4
156%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -176 911.8 N/A
US
Abbvie Inc
NYSE:ABBV
59.5
412%
US
Amgen Inc
NASDAQ:AMGN
38
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.2
42%
US
Gilead Sciences Inc
NASDAQ:GILD
939
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -483 N/A
AU
CSL Ltd
ASX:CSL
34.5
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -128.5 N/A
EV/EBITDA Multiple
EBITDA Growth
NO
Arcticzymes Technologies ASA
OSE:AZT
Average EV/EBITDA: 21.1
38.8
181%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 827.3 N/A
US
Abbvie Inc
NYSE:ABBV
14.9
28%
US
Amgen Inc
NASDAQ:AMGN
17.7
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -525.9 N/A
AU
CSL Ltd
ASX:CSL
21.2
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.1 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -103.2 N/A
EV/EBIT Multiple
EBIT Growth
NO
Arcticzymes Technologies ASA
OSE:AZT
Average EV/EBIT: 30
68.8
314%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -212 375.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.9
88%
US
Amgen Inc
NASDAQ:AMGN
33.4
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -511.9 N/A
AU
CSL Ltd
ASX:CSL
26.4
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.9
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -75.2 N/A

See Also

Discover More
Back to Top